175 related articles for article (PubMed ID: 29247010)
21. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
[TBL] [Abstract][Full Text] [Related]
22. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
[TBL] [Abstract][Full Text] [Related]
23. Structural insight into Wnt signaling inhibition by Clostridium difficile toxin B.
Chen P; Tao L; Liu Z; Dong M; Jin R
FEBS J; 2019 Mar; 286(5):874-881. PubMed ID: 30347517
[TBL] [Abstract][Full Text] [Related]
24. Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS.
Albesa-Jové D; Bertrand T; Carpenter EP; Swain GV; Lim J; Zhang J; Haire LF; Vasisht N; Braun V; Lange A; von Eichel-Streiber C; Svergun DI; Fairweather NF; Brown KA
J Mol Biol; 2010 Mar; 396(5):1260-70. PubMed ID: 20070948
[TBL] [Abstract][Full Text] [Related]
25. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
26. Amino Acid Differences in the 1753-to-1851 Region of TcdB Influence Variations in TcdB1 and TcdB2 Cell Entry.
Hunt JJ; Larabee JL; Ballard JD
mSphere; 2017; 2(4):. PubMed ID: 28776043
[No Abstract] [Full Text] [Related]
27. Small efficient cell-penetrating peptides derived from scorpion toxin maurocalcine.
Poillot C; Bichraoui H; Tisseyre C; Bahemberae E; Andreotti N; Sabatier JM; Ronjat M; De Waard M
J Biol Chem; 2012 May; 287(21):17331-17342. PubMed ID: 22433862
[TBL] [Abstract][Full Text] [Related]
28. TcdB from hypervirulent Clostridium difficile exhibits increased efficiency of autoprocessing.
Lanis JM; Hightower LD; Shen A; Ballard JD
Mol Microbiol; 2012 Apr; 84(1):66-76. PubMed ID: 22372854
[TBL] [Abstract][Full Text] [Related]
29. Binding of Clostridium difficile toxins to human milk oligosaccharides.
El-Hawiet A; Kitova EN; Kitov PI; Eugenio L; Ng KK; Mulvey GL; Dingle TC; Szpacenko A; Armstrong GD; Klassen JS
Glycobiology; 2011 Sep; 21(9):1217-27. PubMed ID: 21610194
[TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
Popoff MR
Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
[TBL] [Abstract][Full Text] [Related]
31. Cholesterol-dependent pore formation of Clostridium difficile toxin A.
Giesemann T; Jank T; Gerhard R; Maier E; Just I; Benz R; Aktories K
J Biol Chem; 2006 Apr; 281(16):10808-15. PubMed ID: 16513641
[TBL] [Abstract][Full Text] [Related]
32. Effective Sequestration of Clostridium difficile Protein Toxins by Calcium Aluminosilicate.
Sturino JM; Pokusaeva K; Carpenter R
Antimicrob Agents Chemother; 2015 Dec; 59(12):7178-83. PubMed ID: 26149988
[TBL] [Abstract][Full Text] [Related]
33. Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP.
Eggimann GA; Buschor S; Darbre T; Reymond JL
Org Biomol Chem; 2013 Oct; 11(39):6717-33. PubMed ID: 23933745
[TBL] [Abstract][Full Text] [Related]
34. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning, overexpression in Escherichia coli, and purification of 6x his-tagged C-terminal domain of Clostridium difficile toxins A and B.
Letourneur O; Ottone S; Delauzun V; Bastide MC; Foussadier A
Protein Expr Purif; 2003 Oct; 31(2):276-85. PubMed ID: 14550648
[TBL] [Abstract][Full Text] [Related]
36. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile.
Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621
[No Abstract] [Full Text] [Related]
37. Sequencing and analysis of the gene encoding the alpha-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile.
Hofmann F; Herrmann A; Habermann E; von Eichel-Streiber C
Mol Gen Genet; 1995 Jun; 247(6):670-9. PubMed ID: 7616958
[TBL] [Abstract][Full Text] [Related]
38. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
39. Clostridium difficile toxin B inhibits the secretory response of human mast cell line-1 (HMC-1) cells stimulated with high free-Ca²⁺ and GTPγS.
Balletta A; Lorenz D; Rummel A; Gerhard R; Bigalke H; Wegner F
Toxicology; 2015 Feb; 328():48-56. PubMed ID: 25497110
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of Clostridium difficile toxins A and B requires an active and functional SREBP-2 pathway.
Papatheodorou P; Song S; López-Ureña D; Witte A; Marques F; Ost GS; Schorch B; Chaves-Olarte E; Aktories K
FASEB J; 2019 Apr; 33(4):4883-4892. PubMed ID: 30592645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
